What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to publicly disclose an investor presentation that Bristol-Myers Squibb Company has posted on its website. This action is taken to comply with Regulation FD and ensure all investors have access to the same information.

Where can I find the investor presentation mentioned in the filing?

The investor presentation can be found on Bristol-Myers Squibb's investor relations website at www.bms.com/investors/events-and-presentations.html. A copy is also attached as Exhibit 99.1 to this Form 8-K.

Does this filing contain new financial results or significant business updates?

This specific 8-K filing primarily serves to provide access to the investor presentation. It does not appear to contain new financial statements or report on material events beyond what is expected to be covered in the presentation itself. Investors should review the attached presentation for the latest company information.

What does it mean that the information is 'not deemed filed'?

When information is furnished and stated as 'not deemed filed,' it means it is being provided to the public for informational purposes, often under Regulation FD, but it does not carry the same legal liabilities as if it were officially "filed" with the SEC under sections like 18 of the Exchange Act. It also won't be automatically incorporated into other SEC filings unless explicitly stated.

BRISTOL MYERS SQUIBB CO 8-K: Regulation FD

Summary

Bristol-Myers Squibb Company (BMY) filed a Current Report on Form 8-K on January 13, 2025, to disclose the posting of an investor presentation on its website. This presentation, dated January 13, 2025, is attached as Exhibit 99.1 to the filing and is available on the company's investor relations website. The filing itself does not contain substantive new financial information but serves to make the investor presentation publicly accessible in accordance with Regulation FD. Investors should note that this filing is primarily a notification of available information rather than a report of material events or financial results. The attached investor presentation is expected to contain the most recent updates, strategic insights, and potentially forward-looking statements from the company. While the information furnished is not deemed "filed" for regulatory purposes, it is important for investors seeking the latest company communications.

Key Highlights

1BMY filed an 8-K on January 13, 2025, to announce the availability of an investor presentation.
2The investor presentation is dated January 13, 2025.
3The investor presentation is accessible on BMY's investor relations website (www.bms.com/investors/events-and-presentations.html).
4A copy of the investor presentation is attached as Exhibit 99.1 to the 8-K filing.
5The filing serves as a Regulation FD disclosure, ensuring broad public access to the presentation.
6This 8-K does not contain new financial statements or material event disclosures beyond the presentation itself.

BRISTOL MYERS SQUIBB CO 8-K Report, Regulation FD Disclosure (Jan 13, 2025)

Summary

Key Highlights

Frequently Asked Questions